Cyclopropane Fatty Acid Accumulation in Transgenic Plants
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating transgenic crop plants that produce commercially meaningful amounts of cyclopropane fatty acids are inefficient, as they often result in only modest accumulation of these modified fatty acids due to limitations in synthesis, degradation, and incorporation into triacylglycerol storage compounds.
Innovation Solution
The expression of cyclopropane fatty acid synthase in plants with elevated 18:1 fatty acid levels, combined with the co-expression of specific fatty acid acyl transferases such as lysophosphatidic acid acyltransferase (LPAT) and diacylglycerol acyltransferase (DGAT), enhances the accumulation of cyclopropane fatty acids by optimizing their synthesis and incorporation into triacylglycerol.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If transgenic crop plants are transformed with source plant genes encoding mFA-producing enzymes, then mFA production capability is introduced, but the accumulation level remains modest (rarely exceeding 20% of total seed FA)
Solution Approach 1:
The patent applies parameter changes by modifying multiple genetic parameters simultaneously: introducing heterologous CPS enzymes from organisms with different biosynthetic capabilities, altering substrate availability through high-oleate backgrounds, and adjusting enzyme expression levels through co-expression of multiple transferases. This multi-parameter approach transforms the biosynthetic pathway to achieve CPA accumulation levels (up to 35%) that exceed natural source plants and previous transgenic attempts.
Solution Approach 2:
The patent creates a composite biosynthetic system by combining elements from multiple sources: heterologous CPS enzymes from bacteria or non-oilseed plants, high-oleate plant backgrounds, and co-expressed acyltransferases from various species. This composite approach integrates complementary functions to overcome the limitations of any single source plant gene, enabling superior mFA production in crop plants.
2Quantity of substance
If multiple genes are co-expressed to optimize synthesis and incorporation, then mFA accumulation increases, but the genetic engineering complexity increases
Solution Approach 1:
The patent segments the biosynthetic optimization into distinct functional modules: (1) substrate provision through high-oleate backgrounds, (2) cyclopropane ring formation through heterologous CPS expression, and (3) product incorporation through co-expressed acyltransferases. This segmentation allows each module to be independently optimized and characterized, reducing the overall complexity of the genetic engineering process while achieving synergistic effects.
Solution Approach 2:
The patent employs universal approaches by using constitutive promoters for gene expression, selecting CPS enzymes from diverse organisms that function across species boundaries, and choosing acyltransferases with broad substrate specificity. This multi-functionality allows the same genetic construction strategy to be applied across different crop plant species, simplifying the overall engineering process despite the multi-gene nature of the solution.
Data Source
AI summary
Heterologous expression of E. coli cyclopropane synthase in genotypic and phenotypic fad2fae1 plants facilitates accumulation of cyclopropane fatty acids. Co-expression of Sterculia foetida transferases, including lysophosphatidic acid acyltransferase, diacylglycerol acyltransferase (DGAT), and Phospholipid Diacyl Glycerol Acyltransferase (PDAT), with E. coli cyclopropane synthase further enhances cyclopropane fatty acid accumulation in fad2fae1 plant seeds.